new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers

You'll see new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers.

This is a surprise. We usually think of Singulair as benign.

But now some patients are reporting insomnia, agitation, anxiety, depression, and similar problems.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote